Changes

Jump to navigation Jump to search
Line 39: Line 39:     
== Compensatory Mechanisms  ==
 
== Compensatory Mechanisms  ==
  −
==== [[Renin Angiotensin Aldosterone System|Renin-angiotensin-aldosterone system]] ====
  −
  −
Causes sodium and water retention by the kidney as well as vasoconstriction. Angiotensin is also recognised as a substance that causes modification and growth in cardiac myocytes and fibroblasts, influencing myocardial remodelling and hypertrophy.
  −
   
==== Sympathetic Nervous System  ====
 
==== Sympathetic Nervous System  ====
 
In heart disease, there is simultaneous a shift of autonomic balance from one of parasympathetic dominance to one of sympathetic dominance. A decrease in systemic blood pressure is detected by baroreceptors (pressure receptors) and mechanoreceptors (stretch receptors) in the carotid sinus, aortic arch and atrial walls. A drop in signals from these receptors  in response to perceived hypoperfusion leads to  an increase in sympathetic activity (and noradrenaline production) and a reduction in parasympathetic activity.  Increased adrenergic activity is mediated via cardiac beta and vascular alpha effects. Elevated sympathetic nervous system activity results in tachycardia, increased contractility, peripheral vasoconstriction and activation of the [[Renin Angiotensin Aldosterone System|renin-angiotensin-aldosterone system (RAAS)]].
 
In heart disease, there is simultaneous a shift of autonomic balance from one of parasympathetic dominance to one of sympathetic dominance. A decrease in systemic blood pressure is detected by baroreceptors (pressure receptors) and mechanoreceptors (stretch receptors) in the carotid sinus, aortic arch and atrial walls. A drop in signals from these receptors  in response to perceived hypoperfusion leads to  an increase in sympathetic activity (and noradrenaline production) and a reduction in parasympathetic activity.  Increased adrenergic activity is mediated via cardiac beta and vascular alpha effects. Elevated sympathetic nervous system activity results in tachycardia, increased contractility, peripheral vasoconstriction and activation of the [[Renin Angiotensin Aldosterone System|renin-angiotensin-aldosterone system (RAAS)]].
    
These effects are initially beneficial, as they act to increase cardiac output and systemic blood pressure. However, over time chronic activation of the sympathetic nervous system becomes detrimental. Noradrenaline stores become depleted, cardiac beta adrenergic receptors become downregulated and uncoupled and myocyte loss results from ischaemia and necrosis.
 
These effects are initially beneficial, as they act to increase cardiac output and systemic blood pressure. However, over time chronic activation of the sympathetic nervous system becomes detrimental. Noradrenaline stores become depleted, cardiac beta adrenergic receptors become downregulated and uncoupled and myocyte loss results from ischaemia and necrosis.
 +
 +
==== [[Renin Angiotensin Aldosterone System|Renin-angiotensin-aldosterone system]] ====
 +
Causes sodium and water retention by the kidney as well as vasoconstriction. Angiotensin is also recognised as a substance that causes modification and growth in cardiac myocytes and fibroblasts, influencing myocardial remodelling and hypertrophy.
    
=== [[Cardiac Hypertrophy|Myocardial hypertrophy]]  ===
 
=== [[Cardiac Hypertrophy|Myocardial hypertrophy]]  ===
Line 57: Line 55:     
Although initially compensatory, increased myocardial mass associated with hypertrophy eventually leads to an increase in myocardial oxygen demand. The increase in oxygen demand outstrips the ability of the coronary circulation to provide sufficient oxygen, which results in myocardial ischaemia. This can result in damage to the myocardium (myocardial necrosis) with replacement by scar tissue (fibrosis), further compromising cardiac function.
 
Although initially compensatory, increased myocardial mass associated with hypertrophy eventually leads to an increase in myocardial oxygen demand. The increase in oxygen demand outstrips the ability of the coronary circulation to provide sufficient oxygen, which results in myocardial ischaemia. This can result in damage to the myocardium (myocardial necrosis) with replacement by scar tissue (fibrosis), further compromising cardiac function.
 +
 +
===Antidiuretic Hormone (ADH)===
 +
In heart failure, there are increased circulating levels of ADH. ADH is usually involved in regulation of osmolality and plays less of a role in regulation of circulating fluid volume. The stimulus for this 'non-osmotic' release of ADH is probably a marked drop in blood pressure. Therefore increased ADH occurs in late stage or severe heart failure.
    
== Classification  ==
 
== Classification  ==
4,503

edits

Navigation menu